Healthcare innovation is thriving.
Cutting-edge drug discovery technologies are becoming accessible to research labs of all sizes, enabling groundbreaking new insights at a rapid pace.
However, much of the earliest-stage innovation is happening largely out of sight of today’s most active healthcare venture capital firms, which tend to focus on well-established entrepreneurs who have prior wins under their belt. Without essential seed funding, promising early-stage ideas often fail to achieve proof-of-concept, never advancing beyond the lab.
ShangPharma Innovation is a healthcare investment firm that specializes in identifying early-stage gems that can advance quickly with the right combination of funding, scientific expertise and operational support. Our management team and executives-in-residence find and de-risk the brilliant, budding ideas that can become transformative medicines and generate significant investment returns.